Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.96 MXN | -0.86% |
|
-0.60% | -16.38% |
| Market Cap | 14.59B 836M 733M 676M 633M 1.19B 78.88B 1.21B 8.12B 3.14B 38.99B 3.14B 3.07B 135B | P/E 2026 * |
6.82x | P/E 2027 * | 6.74x |
|---|---|---|---|---|---|
| Enterprise Value | 18.45B 1.06B 927M 855M 800M 1.5B 99.76B 1.53B 10.27B 3.98B 49.31B 3.97B 3.88B 171B | EV / Sales 2026 * |
1.01x | EV / Sales 2027 * | 0.94x |
| Free-Float |
68.95% | Yield 2026 * |
5.36% | Yield 2027 * | 7.34% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -0.86% | ||
| 1 week | -0.60% | ||
| Current month | -6.38% | ||
| 1 month | -6.67% | ||
| 3 months | -13.38% | ||
| 6 months | -17.26% | ||
| Current year | -16.38% |
| 1 week | 14.24 |  | 15.16 |
| 1 month | 14.24 | | 16.19 |
| Current year | 14.24 | | 19.48 |
| 1 year | 14.24 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -0.60% | -27.90% | +8.48% | 836M | |
| +7.13% | +9.97% | +55.80% | +160.09% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +55.96% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.06% | 448B | |
| +0.99% | +4.85% | +28.17% | +23.89% | 332B | |
| +1.82% | +8.19% | +40.04% | +27.95% | 293B | |
| +0.22% | +6.75% | +31.30% | +42.34% | 286B | |
| +0.73% | +8.53% | -27.33% | -39.55% | 215B | |
| +1.56% | +6.14% | +29.30% | +60.97% | 193B | |
| +3.26% | +3.33% | +15.55% | +68.24% | 159B | |
| Average | +2.30% | +7.65% | +25.10% | +49.94% | 361.69B | |
| Weighted average by Cap. | +3.85% | +8.93% | +41.74% | +80.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.32B 1.05B 921M 849M 795M 1.49B 99.07B 1.52B 10.2B 3.95B 48.96B 3.94B 3.86B 170B | 19.24B 1.1B 967M 891M 834M 1.56B 104B 1.6B 10.71B 4.14B 51.41B 4.14B 4.05B 178B |
| Net income | 2.14B 122M 107M 98.97M 92.66M 174M 11.55B 177M 1.19B 460M 5.71B 460M 450M 19.8B | 2.25B 129M 113M 104M 97.61M 183M 12.17B 187M 1.25B 485M 6.01B 484M 474M 20.86B |
| Net Debt | 3.86B 221M 194M 179M 167M 314M 20.88B 321M 2.15B 832M 10.32B 831M 813M 35.78B | 3.46B 199M 174M 160M 150M 282M 18.73B 288M 1.93B 746M 9.26B 746M 729M 32.1B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | MXN 14.96 | -0.86% | 3,986,049 |
| 25/06/26 | MXN 15.09 | +2.65% | 4,110,913 |
| 24/06/26 | MXN 14.70 | +2.37% | 3,239,505 |
| 23/06/26 | MXN 14.36 | +0.28% | 3,369,521 |
| 22/06/26 | MXN 14.32 | -4.85% | 4,548,372 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
